EFFECT OF MELATONIN, PIOGLITAZONE AND THEIR COMBINATION ON FRUCTOSE INDUCED-INSULIN RESISTANT DIABETES IN RATS.
Keywords:
Insulin resistant diabetes, Lipid peroxidation, Melatonin, PioglitazoneAbstract
Present study investigated the effects of melatonin, pioglitazone and their combination on fructose induced insulin resistant diabetes in rats. Administration of fructose 10% w/v ad libitum in a feeding bottle for 20 days produced insulin resistant diabetes, dyslipidemia and oxidative stress. Increase in serum glucose, insulin, total cholesterol, triglycerides and decrease in HDL levels were observed. In addition to insulin resistance, diabetes induced oxidative stress was observed by increase in TBARS and decrease in GSH levels. Treatment with pioglitazone (5mg and 10mg/kg/day p.o.), melatonin (100µg and 200µg/kg/day i.p.) and pioglitazone (5mg/kg/day p.o.) in combination with melatonin (100µg.kg/day i.p.) were started in insulin resistant diabetic rats after 20 days of fructose administration. The treatment with pioglitazone and melatonin alone and their combination attenuated fructose-induced insulin resistant diabetes as observed by a decrease in serum glucose, serum insulin and lipid levels. Further these results demonstrated that serum glucose, insulin and lipid levels were significantly lowered (p<0.05) in combination group as compared to fructose treated groups as well as with individual groups of pioglitazone and melatonin. The combination group improved the levels of TBARS and GSH also. These effects are probably due to reduction of insulin resistance via decrease in oxidative stress and control of hyperglycemia (P<0.05) in combination group as compared to fructose treated groups as well as with individual groups of pioglitazone and melatonin. The combination group improved the levels of TBARS and GSH also. These effects are probably due to reduction of insulin resistance via decrease in oxidative stress and control of hyperglycemia.
Downloads
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).